These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 20575052)

  • 1. Potential use of nanostructured lipid carriers for topical delivery of flurbiprofen.
    González-Mira E; Nikolić S; García ML; Egea MA; Souto EB; Calpena AC
    J Pharm Sci; 2011 Jan; 100(1):242-51. PubMed ID: 20575052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and ocular tolerance of flurbiprofen loaded ultrasound-engineered NLC.
    Gonzalez-Mira E; Egea MA; Garcia ML; Souto EB
    Colloids Surf B Biointerfaces; 2010 Dec; 81(2):412-21. PubMed ID: 20719479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanostructured lipid carriers (NLC) based topical gel of flurbiprofen: design, characterization and in vivo evaluation.
    Han F; Yin R; Che X; Yuan J; Cui Y; Yin H; Li S
    Int J Pharm; 2012 Dec; 439(1-2):349-57. PubMed ID: 22989987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved and safe transcorneal delivery of flurbiprofen by NLC and NLC-based hydrogels.
    Gonzalez-Mira E; Nikolić S; Calpena AC; Egea MA; Souto EB; García ML
    J Pharm Sci; 2012 Feb; 101(2):707-25. PubMed ID: 22012873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery.
    Gonzalez-Mira E; Egea MA; Souto EB; Calpena AC; García ML
    Nanotechnology; 2011 Jan; 22(4):045101. PubMed ID: 21169662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanostructured lipid carriers-based flurbiprofen gel after topical administration: acute skin irritation, pharmacodynamics, and percutaneous absorption mechanism.
    Song A; Su Z; Li S; Han F
    Drug Dev Ind Pharm; 2015; 41(9):1488-92. PubMed ID: 25231972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation, characterization and in vitro-in vivo evaluation of flurbiprofen-loaded nanostructured lipid carriers for transdermal delivery.
    Kawadkar J; Pathak A; Kishore R; Chauhan MK
    Drug Dev Ind Pharm; 2013 Apr; 39(4):569-78. PubMed ID: 22639934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pluronic lecithin organogel as a topical drug delivery system.
    Pandey M; Belgamwar V; Gattani S; Surana S; Tekade A
    Drug Deliv; 2010 Jan; 17(1):38-47. PubMed ID: 22747074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of nanostructured lipid carriers for transdermal delivery of flurbiprofen.
    Han F; Li S; Yin R; Shi X; Jia Q
    Drug Dev Ind Pharm; 2008 Apr; 34(4):453-8. PubMed ID: 18401788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery.
    Noor NM; Sheikh K; Somavarapu S; Taylor KMG
    Eur J Pharm Biopharm; 2017 Aug; 117():372-384. PubMed ID: 28412472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanostructured lipid carriers (NLC) based controlled release topical gel of clobetasol propionate: design and in vivo characterization.
    Nagaich U; Gulati N
    Drug Deliv Transl Res; 2016 Jun; 6(3):289-98. PubMed ID: 27072979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel vehicle based on cubosomes for ophthalmic delivery of flurbiprofen with low irritancy and high bioavailability.
    Han S; Shen JQ; Gan Y; Geng HM; Zhang XX; Zhu CL; Gan L
    Acta Pharmacol Sin; 2010 Aug; 31(8):990-8. PubMed ID: 20686524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and characterization of a novel controlled release drug delivery system based on nanostructured lipid carriers gel for meloxicam.
    Khurana S; Jain NK; Bedi PM
    Life Sci; 2013 Nov; 93(21):763-72. PubMed ID: 24113071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulating fluticasone propionate in novel PEG-containing nanostructured lipid carriers (PEG-NLC).
    Doktorovová S; Araújo J; Garcia ML; Rakovský E; Souto EB
    Colloids Surf B Biointerfaces; 2010 Feb; 75(2):538-42. PubMed ID: 19879736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dermal flurbiprofen nanosuspensions: Optimization with design of experiment approach and in vitro evaluation.
    Oktay AN; Karakucuk A; Ilbasmis-Tamer S; Celebi N
    Eur J Pharm Sci; 2018 Sep; 122():254-263. PubMed ID: 29981401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of artemether-loaded nanostructured lipid carrier (NLC) formulation for topical application.
    Nnamani PO; Hansen S; Windbergs M; Lehr CM
    Int J Pharm; 2014 Dec; 477(1-2):208-17. PubMed ID: 25290810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid nanocapsules for dermal application: a comparative study of lipid-based versus polymer-based nanocarriers.
    Abdel-Mottaleb MM; Neumann D; Lamprecht A
    Eur J Pharm Biopharm; 2011 Sep; 79(1):36-42. PubMed ID: 21558002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of ibuprofen-loaded nanostructured lipid carrier-based gels: characterization and investigation of in vitro and in vivo penetration through the skin.
    Sütő B; Berkó S; Kozma G; Kukovecz Á; Budai-Szűcs M; Erős G; Kemény L; Sztojkov-Ivanov A; Gáspár R; Csányi E
    Int J Nanomedicine; 2016; 11():1201-12. PubMed ID: 27099487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies.
    Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A
    Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tadalafil-loaded nanostructured lipid carriers using permeation enhancers.
    Baek JS; Pham CV; Myung CS; Cho CW
    Int J Pharm; 2015 Nov; 495(2):701-9. PubMed ID: 26423175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.